Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024 [Yahoo! Finance]
Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024 [Yahoo! Finance]
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024 [Yahoo! Finance]